About
Dr. Otis W. Brawley has served as an Agilent director since November 2021 and is a member of the Compensation Committee. Since 2019 he has been the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University, and from 2007 to 2018 he served as Chief Medical and Scientific Officer at the American Cancer Society. He also serves on the boards of Incyte Corporation, Lyell Immunopharma, Inc. and PDS Biotechnology Corp.
Roles
Agilent Technologies, Inc.
Director · Current role
November 2021–present
Johns Hopkins University
Bloomberg Distinguished Professor of Oncology and Epidemiology
2019 - present
American Cancer Society
Chief Medical and Scientific Officer
2007 - 2018
Emory University
Professor of Hematology, Oncology, Medicine and Epidemiology
2001 - 2018
External Roles
Incyte Corporation
Director
September 2021 - present
Lyell Immunopharma, Inc.
Director
April 2021 - present
PDS Biotechnology Corp
Director
November 2020 - present
Director Compensation
FY 2025Cash retainer
$105,000
ComponentBoard and committee cash retainers earned in FY2025
Stock awards
$220,426
ComponentAnnual stock grant, ASC 718 grant-date fair value (1,819 shares)
Total
$325,426
Also at Agilent Technologies, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.